A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. - Wikidata - awgldk - TriplyDB

A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

http://www.wikidata.org/entity/Q35018038

about

Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.How I treat: the selection and acquisition of unrelated cord blood grafts.Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant.Evaluation of Initial Telomere Length and Changes after Transplantation in Adult Double-Unit Cord Blood Transplant Recipients The use of back-up units to enhance the safety of unrelated donor cord blood transplantation Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.Another case of acute cardiopulmonary toxicity with cord blood infusion: is dextran the culprit?Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities."No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.Umbilical cord blood transplantation: review of factors affecting the hospitalized patient.Plasma-depleted versus red cell-reduced umbilical cord blood.Current thawing and infusion practice of cryopreserved cord blood: the impact on graft quality, recipient safety, and transplantation outcomes.Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation.Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia Cord blood transplantation in Western Australia.Leukapheresis in non-cytokine-stimulated donors with a new apheresis system: first-time collection results and evaluation of subsequent cryopreservation.A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units.How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions.

P2860

Q33456839-21370E33-6377-4400-A978-F0BBFE8D38F3 Q34310952-8070430F-C78A-4979-9F96-1681B97BE0E8 Q34707580-6915F9E6-6D74-456C-82D3-A2B14C1D9F2B Q34754318-026D6165-54DB-4B93-A186-49A2F2216C7F Q34802425-D4B2AAAC-A461-4A8B-9749-5A9D3DD38B8F Q35167190-B31617A5-F1A6-413D-B971-E1E4C9ABDF0D Q35177492-1EF543C4-E671-4C8B-8802-3BD529CA8A41 Q35190671-6CD3E7E7-940E-4851-AC8E-0589108CE9EF Q35514288-547D54F4-2917-47AA-B811-14F33D966BFA Q35738453-A4ED9163-E9B2-4745-9B63-50B94412F5E7 Q35830784-4824E414-6BCB-4426-AC91-0D36A90CFCCC Q36163589-7F61A20E-3D7F-4C20-A457-502F0E28DBC8 Q36206337-2333E10D-A339-4C65-8CD4-9FDE0170D326 Q36674480-78BEEEFE-2747-4F76-AB35-67589C79F7BE Q36905573-11136AFE-4B25-4C12-907D-D183F355DD25 Q36905580-449D6128-B378-4D87-B5BC-AA933371255A Q36936090-AB11A3AC-270A-4C19-85C3-6C865F86C5AB Q37674034-B65A5029-A610-43A0-93DD-99E54752138D Q37674071-442C4FCF-A6C2-435E-95F7-BF50D7385A2D Q38113482-8FC9B210-0A06-4038-84C7-C92C00EE301A Q38210864-87CC434F-E5E6-4D00-887E-E6378E373FEE Q38217398-FFDBCDF6-6C3C-452F-99D4-D634FD19256A Q38636111-38E1061A-B120-48AA-A110-CBB0673DE3A9 Q38747929-D633BE1F-7E51-4D77-BB8D-6A568FFA8CA7 Q40122835-E4792ADA-F037-47CA-BFEE-4D34C031E390 Q41411372-90A820DF-063F-4074-ACBE-2BD799E9EC07 Q44217091-A8D1E495-1B81-48CC-9918-56D489C4C24B Q47377106-369AEC6C-DC86-4EE2-A6CA-4692D9EA61E5 Q48134193-96D270B2-DB13-4DC5-B03C-F389A7F9EAB4 Q48324284-D81888E0-62CF-4A38-B7DD-9C32F819A48E Q50452316-AEF5489F-BC76-46B2-BB95-6559730C24A3

P2860

A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

http://www.wikidata.org/entity/Q35018038

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A "no-wash" albumin-dextran di ...... of serious infusion reactions.

@ast

A "no-wash" albumin-dextran di ...... of serious infusion reactions.

@en

type

label

A "no-wash" albumin-dextran di ...... of serious infusion reactions.

@ast

A "no-wash" albumin-dextran di ...... of serious infusion reactions.

@en

prefLabel

A "no-wash" albumin-dextran di ...... of serious infusion reactions.

@ast

A "no-wash" albumin-dextran di ...... of serious infusion reactions.

@en

P1433

Q35018038-3F0FD56B-D5DF-4C98-B787-E5C3B1E799BA

P1476

Q35018038-E0DD1BDC-BFEA-43B1-9FD5-4CF8C7D3814F

P2093

Q35018038-061DAEFA-2123-4B2D-BCA5-65DA6C6EA312

Q35018038-3C4F5ABF-86A6-427C-A2BC-BBC18A00A013

Q35018038-6C5A3D67-503C-4736-A1F3-5E49D5E45332

Q35018038-7286D989-8E97-45C6-9841-EC878BC35DB7

Q35018038-A7683540-573E-409F-9459-5AE1C9B79340

Q35018038-A81EBC55-536F-43C8-9EA1-E0ACACC61315

Q35018038-C02A0D2A-D50B-4AD7-9A94-E182FF3C8280

Q35018038-E6F2855B-EABB-41CF-BEF9-468235D3CC7C

P2860

Q35018038-294B3DD1-A9D1-4C7F-ABBD-18E3E0153F55

Q35018038-325C077E-A8FA-4CA2-9EFB-07C70ADB752C

Q35018038-46D01D1F-35F4-4245-AA58-5985CA76FC98

Q35018038-4CCF68CC-0FEE-4471-807B-273B5A054FA1

Q35018038-91636B60-842A-406A-A5E9-1628F8988ED7

Q35018038-E916C0CE-253F-49C6-B776-A2FCA37EB993

Q35018038-F441720D-8237-474B-9AA7-D3F4C99EB31F

Q35018038-FB26A418-091B-4781-933B-D0FC5F48C83C

P304

Q35018038-5C5C3C44-CCF3-475E-99CD-0FD7469AF9B3

P31

Q35018038-58D4E91D-6C2F-41CA-9886-C307562C0E10

P356

Q35018038-279BB9C7-0074-439E-9869-05641479D9AB

P433

Q35018038-8A9128FF-044D-4B60-9ED6-DB1090DE9706

P478

Q35018038-6164D9DA-929E-4137-8DE7-4968E7322D03

P577

Q35018038-3E25D19E-55EB-48E2-8F9D-4F26E2D84405

P5875

Q35018038-098D78B5-0717-4886-B5D3-C4409AB1494B

P698

Q35018038-E31898BC-F358-408F-8776-ADF0EB52AE33

P932

Q35018038-5623A2A4-64CD-4519-ACD5-2C82E14C982D

P356

J.BBMT.2009.08.009

P1433

Biology of Blood and Marrow Transplantation

P1476

A "no-wash" albumin-dextran di ...... of serious infusion reactions.

@en

P2093

Allison Schaible

http://www.w3.org/2001/XMLSchema#string

Andromachi Scaradavou

http://www.w3.org/2001/XMLSchema#string

Glenn Heller

http://www.w3.org/2001/XMLSchema#string

Juliet N Barker

http://www.w3.org/2001/XMLSchema#string

Michelle Abboud

http://www.w3.org/2001/XMLSchema#string

Rebecca Hawke

http://www.w3.org/2001/XMLSchema#string

Robert D Rice

http://www.w3.org/2001/XMLSchema#string

Vincent La Russa

http://www.w3.org/2001/XMLSchema#string

P2860

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Patient care during infusion of hematopoietic progenitor cells.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced.

Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.

Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment.

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

P304

1596-1602

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2009.08.009

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38073351

http://www.w3.org/2001/XMLSchema#string

P698

19896084

http://www.w3.org/2001/XMLSchema#string

P932

3105472

http://www.w3.org/2001/XMLSchema#string